Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by stingray88on Jan 21, 2021 12:01pm
95 Views
Post# 32345394

RE:RE:RE:Volume

RE:RE:RE:Volume
moonball32 wrote: Insiders need to declare the shares they purchase, it's the securities regulation and I have not seen any reports to support that yet. I think a lot of investors were betting on the last nr to say that tests were all done, great results and applications submitted to regulatory bodies. Obviously that didn't happen and the wait continues, hence the sell off. So we wait till we get closer to next NR and then same exuberance will take hold, hopefully the results will support applications being filed, then upward movement will be sustainable not just hype.


I agree. The news was not what was expected. There will now be a cooling off period. My fear is the wait period may take a couple of weeks (at the rate health care operates). With the volume declining because of no catylsts , the share price may drift further. IMO
<< Previous
Bullboard Posts
Next >>